post-approval economics for new antibiotics: q&a
Published 4 years ago • 252 plays • Length 41:29Download video MP4
Download video MP3
Similar videos
-
12:41
post-approval economics for new antibiotics: supply chain robustness, inventory build, and qa
-
18:19
post-approval economics for new antibiotics: post-marketing commitments and ast development
-
4:50
post-approval economics for new antibiotics: additional economic considerations
-
31:27
post-approval economics for new antibiotics: sales and marketing
-
9:39
bootcamp post-approval economics for new antibiotics: introduction & background (asm/escmid 2019)
-
9:29
drug companies aren’t making new antibiotics. is there an economic cure?
-
15:44
antibiotics for covid? (update #151)
-
6:23
how can we solve the antibiotic resistance crisis? - gerry wright
-
1:07:02
meliodosis - infectious diseases - copm weekly webinar 24
-
1:02:01
secure: improving access to antibiotics through new economic models
-
42:20
q&a: gardp and venatorx collaboration to develop new treatment for multidrug-resistant infections
-
1:26:40
an introduction to antibiotic research and development (r&d)
-
44:21
the urgent need for a new generation of antibiotics
-
44:26
a new economic model for drug development: the antibiotic susceptibility bonus - dr. olof lindahl
-
1:04:56
principles of antibiotics prescribing - infectious diseases - copm weekly webinar 24
-
1:28:01
non traditional antibacterial therapeutic options and challenges
-
2:09
who urges governments to support development of new antibiotics
-
8:46
the financial barrier to developing antibiotics? no big payday for drug companies
-
1:33:02
ws 14 – development of a sustainable market for new, resistance-breaking antibiotics
-
1:28:10
from discovery to ind: roadmap to a successful antibacterial project
-
14:42
antibiotics for gram positive infections (antibiotics - lecture 4)